Details of the Drug-Related molecule(s) Expression Atlas

General Information of Drug (ID: DMEQLC4)

Drug Name
DX-9065 Drug Info
Synonyms DX-9065 (enteric-coated tablet)
Indication
Disease Entry ICD 11 Status REF
Coagulation defect 3B10.0 Discontinued in Phase 2 [1]
Cross-matching ID
PubChem CID
122129
TTD Drug ID
DMEQLC4

Molecule(s) Related to This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Coagulation factor Xa (F10) TTCIHJA FA10_HUMAN Inhibitor [2]

The Expression Level of Molecule(s) in Normal Tissue of Major ADME-Related Organs

Molecule Molecule Type Gene Name Liver Colon Kidney Small Intestine
Coagulation factor Xa (F10) DTT F10 7.763 4.672 3.248 4.609
Molecule Expression Atlas in Normal Tissue of Major ADME-related organs

The Expression Level of Molecule(s) between Disease Section and Healthy Individual Tissue

The Studied Disease Coagulation defect
ICD Disease Classification 3B10.0
Molecule Name Molecule Type Gene Name p-value Fold-Change Z-score
Coagulation factor Xa (F10) DTT F10 4.84E-02 -0.28 -0.9
Molecular Expression Atlas between Disease Section and Healthy Individual Tissue

References

1 DX-9065a Daiichi. Curr Opin Investig Drugs. 2003 Sep;4(9):1105-12.
2 Semuloparin for the prevention of venous thromboembolic events in cancer patients. Drugs Today (Barc). 2012 Jul;48(7):451-7.